Shannon M. Parisotto, Chief Executive Vice President of Discovery and Safety Assessment at Charles River Laboratories International, Inc., filed a Form 4 on August 20, 2026, disclosing a same-day stock option exercise and share sale on August 19, 2026, conducted under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Option exercise: Parisotto exercised 2,039 stock options at an exercise price of $194.12 per share on August 19, 2026.
  • Shares sold: 2,039 shares of Common Stock were sold at $294.12 per share on August 19, 2026.
  • Direct ownership after transactions: Parisotto directly held 4,807 shares of Common Stock following the reported transactions.
  • Indirect holdings: An additional 9,680 shares are held indirectly by trust, and 28,510 shares are held indirectly by Karpathos Investments LLC.
  • 10b5-1 plan: The exercise and sale occurred under a Rule 10b5-1 trading plan initially adopted on March 4, 2026.
  • Options remaining: Parisotto retains 2,039 stock options with an exercise price of $194.12, expiring May 26, 2033.

Parisotto's Option Exercise and Sale at Charles River Laboratories

According to the Form 4 filed with the SEC, Shannon M. Parisotto, who serves as Chief Executive Vice President of Discovery and Safety Assessment at Charles River Laboratories International, Inc. (NYSE:CRL), executed a same-day option exercise and sale on August 19, 2026. The transaction involved the exercise of 2,039 stock options at a conversion price of $194.12 per share, followed by the immediate sale of 2,039 shares of Common Stock at $294.12 per share.

The filing indicates that the transaction was made pursuant to a Rule 10b5-1 trading plan that Parisotto initially adopted on March 4, 2026. The Form 4 notes the transaction code "M" for the option exercise and "S" for the open-market sale. Following these transactions, Parisotto directly held 4,807 shares of Common Stock, down from 6,846 shares prior to the sale.

In addition to direct holdings, the filing discloses indirect beneficial ownership of 9,680 shares held by trust and 28,510 shares held by Karpathos Investments LLC. Parisotto also retains 2,039 stock options with an exercise price of $194.12 per share, exercisable as of May 26, 2024, with an expiration date of May 26, 2033, and a reported price of $0 for the derivative security in this transaction.

What Was Disclosed

The filing reports a single-day option exercise and share sale by a senior officer of Charles River Laboratories International, Inc., executed under a pre-established 10b5-1 plan, with resulting direct beneficial ownership of 4,807 shares of Common Stock.